Strengthening prevention programs to eliminate cervical cancer in the Nordic countries
- PMID: 18446530
- DOI: 10.1080/00016340801986771
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries
Abstract
Disease trend studies based on birth cohort analysis and serological studies indicate that recent generations have a higher prevalence of oncogenic Human Papilloma Virus (HPV) types, and are likely to be at higher risk of cancer than previous generations. This implies that prevention strategies to protect young populations from HPV-associated cancers need to be strengthened, and hence organized implementation of vaccination and better screening programs are being considered. In this context, randomized large-scale policy evaluations will be instrumental in accelerating disease control and improve effective prevention programs. This report shares experiences from Nordic countries with examples of prevention strategies through vaccination and cervical screening. The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.
Similar articles
-
Recommendations for cervical cancer prevention in Asia Pacific.Vaccine. 2008 Aug 19;26 Suppl 12:M89-98. doi: 10.1016/j.vaccine.2008.06.020. Vaccine. 2008. PMID: 18945418
-
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18. Vaccine. 2007. PMID: 17292517 Review.
-
Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6. Int J Infect Dis. 2007. PMID: 18162242 Review.
-
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Gynecol Oncol. 2008. PMID: 18653221 Review.
-
Integrating human papillomavirus vaccination in cervical cancer control programmes.Public Health Genomics. 2009;12(5-6):352-61. doi: 10.1159/000214925. Epub 2009 Aug 11. Public Health Genomics. 2009. PMID: 19684447 Review.
Cited by
-
Trends in Mortality Due to Malignant Neoplasms of Female Genital Organs in Poland in the Period 2000-2021-A Population-Based Study.Cancers (Basel). 2024 Mar 3;16(5):1038. doi: 10.3390/cancers16051038. Cancers (Basel). 2024. PMID: 38473394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical